Vident Advisory’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$43.5M Buy
177,838
+4,986
+3% +$1.16M 0.37% 51
2025
Q4
$35.8M Buy
172,852
+9,441
+6% +$1.87M 0.33% 66
2025
Q3
$30.3M Buy
163,411
+4,373
+3% +$749K 0.29% 75
2025
Q2
$24.3M Buy
159,038
+10,873
+7% +$1.67M 0.27% 88
2025
Q1
$24.6M Buy
148,165
+5,870
+4% +$918K 0.36% 60
2024
Q4
$20.6M Buy
142,295
+27,035
+23% +$4.19M 0.36% 60
2024
Q3
$18.7M Sell
115,260
-9,047
-7% -$1.44M 0.47% 42
2024
Q2
$18.2M Sell
124,307
-262,809
-68% -$39.1M 0.5% 36
2024
Q1
$61.2M Buy
387,116
+95,272
+33% +$15.2M 1.28% 4
2023
Q4
$45.7M Buy
291,844
+36,320
+14% +$5.57M 1.15% 6
2023
Q3
$39.8M Buy
+255,524
New +$42.2M 1.23% 5

Other funds holding JNJ

Vident Advisory's JNJ Position: Q1 2026 in Review

Vident Advisory increased its Johnson & Johnson (JNJ) stake by 2.9% in Q1 2026, buying an estimated $1.16M and bringing the position to 177,838 shares worth $43.5M. The position accounts for 0.37% of the portfolio, ranked #51.

Vident Advisory first reported a position in JNJ in Q3 2023 and has held it in 11 quarters since. The position peaked at $61.2M in Q1 2024. 4,614 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Vident Advisory held 177,838 shares of Johnson & Johnson worth $43.5M as of Q1 2026.
  • Vident Advisory bought 4,986 Johnson & Johnson shares in Q1 2026, an estimated $1.16M.
  • Johnson & Johnson made up 0.37% of Vident Advisory's portfolio in Q1 2026, its #51 holding.
  • Vident Advisory first reported a position in Johnson & Johnson in Q3 2023 and has held it in 11 quarters since.
  • Vident Advisory's Johnson & Johnson position peaked at $61.2M in Q1 2024.
  • 4,614 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.